← HadIt.com

VA Asthma Claims: How Asthma Gets Rated and What You'll Earn

Asthma is the third leg of the chronic respiratory cluster — paired with rhinitis and chronic sinusitis, and frequently filed as secondary to GERD (microaspiration / vagal-bronchospasm). It is also a textbook PACT Act §1119 presumptive condition for Gulf War and post-9/11 burn-pit veterans. This guide covers the 38 CFR 4.97 DC 6602 rating ladder up to 100% (FEV1 % predicted and FEV1/FVC ratio), the shared-airway-inflammation pathway that makes asthma an extension of the upper-airway claim, the 5-field peak-flow log + bronchodilator-response evidence strategy, the C&P exam single-snapshot FEV1 measurement gap, and three common denial patterns. No lawyers, no jargon, veteran-to-veteran.

Calculate Your Combined Rating → Secondary Conditions Guide →
Up to 100% DC 6602 max rating
38 CFR 4.97 DC 6602 asthma schedule
PACT §1119 Presumptive for burn-pit vets
2026 rates ~$4,233/mo tax-free at 100%
38 CFR 4.97 — Asthma rating schedule

DC 6602 asthma rating criteria: the exact federal standard.

Asthma (bronchial asthma, ICD-10 J45.x) is rated under 38 CFR 4.97 using Diagnostic Code 6602. The rating formula is a pulmonary function test (PFT) ladder keyed to FEV1 % predicted and FEV1/FVC ratio, with frequency of exacerbations and ER / hospitalization history recognized as severity anchors. The five levels: 0% — intermittent, no more than two episodes per year with no chronic symptoms; 10% — persistent mild with FEV1 ≥80% predicted, FEV1/FVC >0.71; 30% — persistent moderate with FEV1 50–79% predicted, FEV1/FVC 0.61–0.70; 60% — persistent severe with FEV1 40–49% predicted, FEV1/FVC ≤0.60; 100% — persistent very severe with FEV1 <40% predicted, FEV1/FVC <0.40, frequent hospitalizations. The diagnostic standard for asthma is reversible airflow obstruction — a 12% or greater and 200 mL or greater FEV1 improvement after bronchodilator administration.

38 CFR 4.97 — Official regulatory reference

Asthma is rated under 38 CFR § 4.97 — DC 6602. The full regulation is at the eCFR link. The VA uses the Respiratory Conditions DBQ at C&P exams. The table below reflects the exact statutory language — not paraphrased or simplified.

Rating DC 6602 Threshold Key Symptom Indicators
0%
Service connected only
Intermittent asthma — no more than two episodes per year with no chronic symptoms. FEV1 typically ≥80% predicted.
Asymptomatic between exacerbations. No daily symptoms. No nighttime awakenings. Service connection at 0% is still valuable because asthma establishes the gateway to many secondary claims (GERD-cluster respiratory claims, chronic bronchitis clustering) and preserves future rating increases as the condition progresses.
10%
~$175/mo (2026 rate)
Persistent mild — FEV1 ≥80% predicted, FEV1/FVC >0.71, daily symptoms, more than two episodes per year.
The 10% level requires daily symptoms with more than two exacerbations per year — even when the FEV1 is at 80% predicted. Many veterans with service-connected rhinitis or sinusitis whose asthma is being recognized for the first time cluster here as a floor — the typical "controlled on low-dose ICS" tier. Rating increases follow as exacerbation frequency accelerates or FEV1 trends down.
30%
~$524/mo (2026 rate)
Persistent moderate — FEV1 50–79% predicted, FEV1/FVC 0.61–0.70, daily symptoms, nighttime awakenings 1–2 times per month.
The 30% rating is paired with the lowest-dose-combination-inhaler tier (low-dose ICS + LABA — Advair, Symbicort) and the typical ER visit 1–2× per year. This is the rating tier where most veterans with asthma secondary to GERD or to rhinitis cluster to begin, and where combined-rating math with rhinitis and sinusitis begins to matter for the 50%+ combined threshold.
60%
~$1,361/mo (2026 rate)
Persistent severe — FEV1 40–49% predicted, FEV1/FVC ≤0.60, daily symptoms, frequent exacerbations.
High-dose ICS-LABA, LAMA add-on (tiotropium), and oral corticosteroid bursts are the typical treatment pattern. Frequent ER visits and activity limitation reported in daily life. The 60% asthma combined with 30% rhinitis and 50% sinusitis pushes the respiratory combined rating across the 80% combined-rating bracket — a major benefits gate.
100%
~$4,233/mo (2026 rate)
Persistent very severe — FEV1 <40% predicted, FEV1/FVC <0.40, frequent hospitalizations, near-continuous symptoms.
The DC 6602 max. Hospitalizations, ICU-level events, biologic therapy (omalizumab/Xolair, mepolizumab/Nucala, dupilumab/Dupixent) for severe-persistent asthma. Compounded with rhinitis and sinusitis, the respiratory-cluster combined-rating math easily clears 100% combined and opens SMC / TDIU / CHAMPVA thresholds. 100% asthma is rare, but real — the strongest filing pairs the PFT data, the peak-flow log, and the biologics / hospitalization records.
The bronchodilator-response diagnostic standard (reversible airflow obstruction)
Asthma diagnosis requires a ≥12% and ≥200 mL FEV1 improvement after bronchodilator administration.

The diagnostic standard for DC 6602 — distinct from COPD and other respiratory conditions under 38 CFR 4.97 — is reversible airflow obstruction: a 12% or greater and 200 mL or greater FEV1 improvement after bronchodilator administration (albuterol, salbutamol) on serial PFT. Without this bronchodilator response, the rating is more likely to be evaluated as COPD (DC 6604) or a different respiratory condition.

The defense for asthma: submit serial PFTs from your pulmonologist that document the bronchodilator response explicitly — many PFTs report the pre-/post-bronchodilator FEV1 but not the percentage change. Request your pulmonologist add the percentage-change and the 200 mL absolute improvement explicitly to the report. Most hospital PFTs already include this; smaller clinic PFTs may need the explicit addition. With the bronchodilator response on the page, the asthma diagnosis is locked in — DC 6602 applies, not DC 6604 COPD.

Diagnostic coding: ICD-10 J45.x for asthma

VA rating decisions use DC 6602, but the underlying ICD-10 code for asthma is J45.x — and which J45.x subcode your pulmonologist uses documents the severity tier in clinical terms. The key subcodes: J45.20 mild intermittent; J45.30 mild persistent; J45.40 moderate persistent; J45.50 severe persistent. A pulmonologist or primary care diagnosis note specifying the J45.x subcode is objective severity evidence and pairs with the PFT report and the medication ladder to anchor the rating. Submit the diagnosis note with the ICD-10 code explicit, not just "asthma" — the subcode is the clinical anchor.

PACT Act §1119 — Asthma as a presumptive respiratory condition

The PACT Act presumptive angle for asthma claims.

Asthma diagnosed after service is explicitly listed as a PACT Act §1119 presumptive condition under 38 CFR 3.320 for veterans who served in a covered PACT Act location during the qualifying window. Unlike hypertension (which is NOT a PACT Act presumptive), asthma is on the standalone list — the law was designed with respiratory-disease cluster claims in mind.

38 CFR 3.320 — PACT Act toxic exposure presumption

The list of chronic respiratory conditions added to the VA's presumptive list under PACT Act §1119 (38 CFR 3.320) includes: asthma diagnosed after service, chronic bronchitis, COPD, constrictive bronchiolitis, pulmonary fibrosis, and chronic rhinosinusitis. The presumption covers veterans who served in Southwest Asia theater from August 2, 1990 (Gulf War) to the present, and post-9/11 veterans (September 19, 2001 or later) who served in qualifying locations.

The strongest respiratory cluster framing: file chronic rhinosinusitis + chronic bronchitis + asthma together under 38 CFR 3.320 — each as its own diagnostic code (DC 6510–6514, DC 6600, DC 6602) with its own rating, all preserved under a single deployment-and-exposure record. The shared-airway-inflammation pathway strengthens the cluster framing medically, but each condition still needs its own diagnostic code evidence. See the HadIt PACT Act Guide → for full presumptive coverage.

The four-step filing walk-through for the PACT Act presumptive angle:

See the full §1119 cluster hub at /pact-act-va-claims for all presumptive respiratory and cardiovascular conditions (asthma, chronic rhinosinusitis, rhinitis aggravator, hypertension aggravator) bundled in one place — the covered-condition tiles, the §1119 effective-date timeline, and the reduced evidentiary burden the VA now carries.

1
Document qualifying PACT Act service in a covered location
Pull your DD-214 and deployment orders. Confirm service in the Gulf War theater (August 2, 1990 to present) — including Iraq, Kuwait, Saudi Arabia, Bahrain, Qatar, the United Arab Emirates, Oman, the Gulf of Aden, the Gulf of Oman, the Persian Gulf, the Red Sea, the Arabian Sea, and the waters off these locations — OR service in a post-9/11 qualifying location on or after September 19, 2001 (Afghanistan, Djibouti, Egypt, Jordan, Lebanon, Syria, Uzbekistan, Yemen, and other Southwest Asia locations).
2
Document asthma diagnosed AFTER service (the key regulatory trigger)
The PACT Act §1119 presumption applies to asthma diagnosed after service. The diagnosis date matters. Submit your post-service pulmonology or primary care diagnosis notes (ICD-10 J45.x — J45.20 mild intermittent, J45.30 mild persistent, J45.40 moderate persistent, J45.50 severe persistent) with the diagnosis date explicit. Burn pit proximity statements, particulate matter exposure, oil-well fire smoke (Kuwait 1991), sulfur-fire smoke (Iraq 2003) buddy statements — these document the in-service exposure even though, under the presumption, you don't have to prove a specific nexus.
3
File VA Form 21-526EZ citing 38 CFR 3.320 presumptive pathway
On the 526EZ, identify asthma as the claimed condition and cite 38 CFR 3.320 / PACT Act §1119 as the legal basis. Submit your DD-214, deployment orders, unit records, buddy statements, and the post-service diagnosis notes. Critically: you do NOT need a private nexus letter — the law presumes service connection. The VA will schedule a C&P exam to assess severity (rating level), not to re-determine service connection. File chronic rhinosinusitis (DC 6510–6514) and chronic bronchitis (DC 6600) at the same time if you have those conditions — the respiratory-cluster filing under one deployment record is the strongest combined-rategy.
4
Attend the C&P exam with PFT, bronchodilator response, peak-flow log, pharmacy records
Bring your serial PFTs from the pulmonologist (with FEV1 % predicted, FEV1/FVC ratio, and the bronchodilator response ≥12% and ≥200 mL improvement documented explicitly), the 5-field peak-flow log tracked prospectively (Section 6), medication reconciliation pharmacy records (albuterol rescue, fluticasone / budesonide ICS, salmeterol / formoterol LABA, tiotropium LAMA, montelukast leukotriene modifier, Xolair / Nucala / Dupixent biologic), ER visit records for acute exacerbations, and any prior hospital discharge summaries. The examiner will measure FEV1 at the exam — your prospective log and serial PFTs establish your typical baseline outside the exam room.
Choose the right path

Four filing paths for asthma — and which one applies to you.

Asthma claims have four distinct legal pathways: direct service connection, PACT Act §1119 presumptive, secondary to a service-connected rhinitis or chronic sinusitis (the shared-airway-inflammation pathway), and secondary to a service-connected GERD. Most veterans have more than one available — and the highest-value strategy is the PACT Act presumptive for eligible Gulf War and post-9/11 burn-pit veterans, with the secondary-to-rhinitis or secondary-to-GERD theory as a strong back-up or co-filing.

Direct Service Connection
38 CFR 3.303 — Direct service connection
Direct SC

You claim asthma as directly caused by an in-service event or condition. Requires: an in-service event, injury, or exposure; current asthma diagnosis meeting the reversible-airflow-obstruction standard; and a nexus opinion linking the two.

Best for: Veterans with documented in-service asthma onset (rare — most in-service respiratory complaints are acute and not diagnosed as asthma), or whose asthma traces clearly to a documented in-service exposure event. The direct SC path is harder than the PACT Act presumptive for asthma because the in-service documentation is rarely asthma-specific.

PACT Act §1119 Presumptive
38 CFR 3.320 — PACT Act toxic exposure presumption
Presumptive Fastest path

Service-connected by law if you served in a qualifying PACT Act location (Gulf War theater from August 2, 1990 to present, or post-9/11 Southwest Asia from September 19, 2001 to present) and you have asthma diagnosed after service. The VA presumes service connection — you don't need to prove a specific nexus or exposure event. Requires: documented qualifying service + asthma diagnosed after service.

Best for: Gulf War and post-9/11 veterans with post-service asthma diagnosis. This is the fastest path and pairs naturally with chronic rhinosinusitis + chronic bronchitis presumptive filings — file all three respiratory conditions together with a single deployment and exposure record. The combined-rating math is powerful: 60% asthma + 50% chronic rhinosinusitis + 30% allergic rhinitis = 90%+ combined rating.

This is the highest-volume winning pathway for asthma claims. See PACT Act Presumptives Guide → for the full list and PACT Act Denied Guide → for veterans whose claim was already denied.

Secondary to Rhinitis / Sinusitis Cluster
38 CFR 3.310(a) — Shared-airway-inflammation secondary
Secondary SC

You claim asthma as caused or aggravated by a service-connected allergic rhinitis (DC 6522) or chronic sinusitis (DC 6510–6514). The mechanism: shared-airway-inflammation — chronic upper-airway inflammation drives eosinophilic and Th2-mediated inflammation downstream into the bronchial mucosa, producing reversible airflow obstruction. This is the clinical concept of "united airway disease" or "one airway disease," well-documented in peer-reviewed pulmonary and ENT literature.

Best for: Veterans with service-connected rhinitis DC 6522 or chronic sinusitis DC 6510–6514 and new-onset or worsening asthma following the upper-airway diagnosis. The strongest argument is to file rhinitis + sinusitis + asthma together with a single ENT + pulmonology co-signed nexus letter addressing the airway-disease module. Combined, 60% asthma + 30% rhinitis + 50% sinusitis = 90%+ combined rating.

This is the highest-value combined-rating framing for respiratory cluster claims. See Rhinitis VA Claims Guide → and Sinusitis VA Claims Guide → for the upper-airway pair.

Secondary to GERD
38 CFR 3.310(a) — GERD-as-secondary respiratory nexus
Secondary SC

You claim asthma as caused or aggravated by a service-connected GERD (DC 7346). The mechanism runs in two parallel routes: (1) microaspiration — chronic reflux of small amounts of gastric content into the airways produces direct bronchial irritation and airway hyperresponsiveness; (2) vagal-mediated bronchospasm — acid in the distal esophagus triggers vagal afferent fibers that produce reflex bronchospasm. Both are recognized causes of "GERD-associated asthma" that worsens when reflux is uncontrolled.

Best for: Veterans with service-connected GERD (DC 7346) and new-onset or worsening asthma following the GERD diagnosis, particularly veterans whose asthma worsens at night (recumbent reflux) or after large meals. The strongest argument: a single pulmonology + GI co-signed nexus letter addressing both mechanisms, plus pharmacy records for the GERD medication ladder (omeprazole, pantoprazole, esomeprazole, famotidine) and the asthma medication ladder.

The 60% asthma + 50% sinusitis + 30% rhinitis = 90%+ combined-rating argument

Combined-rating math for the full respiratory cluster: 60% asthma (DC 6602) + 50% chronic sinusitis (DC 6510 max) + 30% allergic rhinitis (DC 6522 max) = 90%+ combined rating. Even moderate tiers stack aggressively: 30% asthma + 30% rhinitis + 50% sinusitis = 75% combined. The 70% combined-rating bracket is a major benefits gate — it unlocks dependents' educational assistance, housing allowance, faster SMC review, and CHAMPVA eligibility once permanent total disability is also established. The strategy: file rhinitis + sinusitis + asthma together under PACT Act §1119 presumptive (38 CFR 3.320) if eligible, OR under 38 CFR 3.310 shared-airway-inflammation secondary nexus if not eligible for presumptive, with a single ENT + pulmonology co-signed nexus letter addressing the airway-disease module. See Combined Ratings Calculator → for your specific math.

What you need to file

Evidence checklist — the seven things that win asthma claims.

An asthma VA claim stands or falls on documented PFT data, the bronchodilator-response diagnostic standard, and a clear medication reconciliation with peak-flow variability. Submit all of these with your initial claim — don't wait for a request.

C&P exam prep — where asthma claims are won or lost

How to prepare for your asthma C&P exam.

The C&P exam for asthma uses a Respiratory Conditions DBQ. The examiner takes FEV1 and FEV1/FVC measurements at the visit, reviews your medication history, and asks about exacerbation frequency and ER visits. The defect: a single-visit FEV1 measurement cannot capture the chronic asthma variability — and many veterans come into the exam with a higher-than-typical reading because the controlled C&P setting is calmer than daily life, OR with a lower-than-typical reading because they just took rescue inhaler medication before driving in. Either direction understates the rating.

The C&P exam single-snapshot FEV1 measurement gap
DC 6602's threshold measurements are objective — but a single 10-minute exam visit cannot capture chronic asthma variability.

The C&P examiner takes one or two FEV1 measurements at rest. Three failure modes push the measurement off the chronic asthma baseline: (1) the exam catches a high-flow day — many veterans are calmer than usual at the controlled C&P setting than during typical daily life with triggers (cold air, exercise, dust, smoke); (2) timing of rescue inhaler — the veteran may have used albuterol before driving to the exam, which artificially opens the airways and produces a higher-than-typical reading; (3) rest effect — the examiner's rest instructions produce a higher FEV1 than typical. A single FEV1 reading also famously varies day-to-day regardless of these factors — that's the asthma-specific variability the C&P exam cannot address.

The defense: (1) bring serial PFTs from your pulmonologist showing FEV1 variability across multiple visits and explicitly documenting the ≥12% and ≥200 mL bronchodilator response; (2) bring the 5-field peak-flow log tracked over 6 to 12 weeks with AM/PM differential and rescue-inhaler puffs; (3) submit pharmacy fill records showing medication escalation to triple therapy (ICS + LABA + LAMA) or biologics (Xolair / Nucala / Dupixent); (4) submit ER visit records and hospitalization history for acute exacerbations; (5) have your pulmonologist write a letter describing your typical baseline outside the exam room.

Use the 5-field peak-flow log to document your asthma variability prospectively:

# Field What to record Why it matters
1
Date
Date of the peak-flow measurement.
 Establishes a chronic baseline across weeks — directly counters the single-snapshot C&P exam problem and documents the day-to-day FEV1 / peak-flow variability that defines asthma.
2
AM Peak Flow (L/min)
Morning peak-flow reading after waking, before using rescue inhaler or controllers.
 The "before-medication" morning reading is typically the lowest flow of the day for most asthmatics — captures the gap between the last dose and the next. Use a peak-flow meter (standard, available OTC). Compare to your personal best to compute the % drop.
3
PM Peak Flow (L/min)
Evening peak-flow reading, after workday stressors and triggers, before evening controller medication.
 The "end-of-day" reading captures the cumulative trigger load and the workday stress impact. The AM/PM differential is the asthma-variability benchmark — a 20%+ drop is the standard diagnostic threshold for variability. Pair with a note about the day (high vs. low trigger exposure, sleep the night before).
4
Rescue Inhaler Puffs
Number of albuterol / salbutamol rescue-inhaler puffs used that day.
 Documents the rescue-inhaler use frequency — a key DC 6602 severity axis. Daily rescue-inhaler use, or nocturnal awakening-driven rescue use, anchors mid-to-high ratings. Track controller adherence alongside rescue use (one without the other is incomplete data).
5
Triggers / Symptoms / Activity Limitation
Triggers that day (cold air, exercise, dust, smoke, allergens); symptoms (wheeze, chest tightness, shortness of breath, cough); activity limitation (missed work, ER visit, exercise avoidance, sleep disruption).
 Documents the real-world asthma impact — what the C&P examiner cannot see from a single-snapshot FEV1. Track any ER visit or urgent care visit with the date, treating facility, and disposition. This column is the human evidence the oscillometric FEV1 number cannot tell.

Additional areas the examiner will probe — prepare honest answers for each:

After the exam — request your C&P exam report

You are entitled to a copy of the C&P exam report. Request it through MyHealtheVet or by calling your regional office. If the examiner recorded a single high FEV1 reading that doesn't reflect your chronic asthma variability, you can submit a rebuttal statement before the rating decision — don't wait until after the denial. Submit your serial PFTs and 5-field peak-flow log as rebuttal evidence.

Full C&P exam prep: C&P Exam Guide — what to expect and how to prepare →

When the VA says no

Three common asthma denial reasons — and how to counter each.

Asthma claims get denied for specific, predictable reasons. Knowing them in advance lets you build the claim to avoid them and fight back effectively if the denial comes anyway.

"Single FEV1 reading ≥80%, denied at 0%"
38 CFR 4.97 — DC 6602 measurement standard

The C&P examiner's single FEV1 reading came in at the 80% threshold — likely after rest, after rescue inhaler, or on a high-flow day — and the rater denied at 0% because the reading did not meet the 10% trigger (FEV1 ≥80% predicted with daily symptoms and more than two episodes per year). Your typical baseline is far below 80% because asthma is by definition variable, but a single high-flow exam reading cannot capture that.

How to counter

Submit serial PFTs from your pulmonologist showing FEV1 variability across multiple visits — most asthmatics show 15–30%+ FEV1 variation week-to-week. Submit the 5-field peak-flow log tracked prospectively over 6 to 12 weeks showing AM/PM differential and rescue-inhaler puffs on bad days — the variability is in the log, not in any single C&P exam reading. Submit the bronchodilator-response documentation showing ≥12% and ≥200 mL FEV1 improvement — this locks in the asthma diagnosis and rules out COPD. Submit ER visit records for intermittent acute exacerbations, with FEV1 measurements during exacerbation below 80%.

"No in-service asthma onset documentation"
38 CFR 3.303 — Direct SC element missing

The rater denies service connection because no in-service respiratory complaints meet the asthma diagnostic standard. Most in-service respiratory complaints are acute (URI / bronchitis episodes, not documented asthma diagnoses) — they cannot satisfy the chronic-asthma regulatory threshold. Direct SC for asthma is the hardest path for exactly this reason.

How to counter

For burn-pit veterans: file under PACT Act §1119 presumptive (38 CFR 3.320) if you served in a covered PACT Act location — no nexus required, just qualifying service + asthma diagnosed after service. For non-presumptive veterans: file asthma as SECONDARY to service-connected rhinitis (DC 6522) or chronic sinusitis (DC 6510–6514) under 38 CFR 3.310 shared-airway-inflammation nexus, OR file asthma as secondary to service-connected GERD (DC 7346) under the microaspiration / vagal-bronchospasm pathway. The legal theory is different: the primary service-connected condition is the in-service event, and the medical nexus between primary and asthma is established through a single ENT + pulmonology co-signed (or pulmonology + GI co-signed) nexus letter.

"Pre-existing asthma, denied as not aggravated by service"
38 CFR 3.310(b) — Aggravation standard

The rater denies service connection because you had childhood or pre-existing asthma before service, and the rater concludes service did not aggravate it beyond the natural progression. The 38 CFR 3.310(b) aggravation standard requires a baseline (pre-service) and a current (post-service) measurement and proof that the current exceeds the natural progression.

How to counter

Build a clear pre-service vs. in-service vs. post-service FEV1 and peak-flow trajectory in lay statements and medical records. Submit a pulmonology nexus letter explicitly invoking the 38 CFR 3.310(b) aggravator standard: "The veteran's asthma, which pre-existed service, was aggravated beyond its natural progression by [in-service event / service-connected primary condition], and the current severity is not due solely to the natural progression of the disease." Any worsening beyond natural progression counts. Buddy statements documenting exercise intolerance, ER visits, and medication escalation during and after service strengthen the file.

All three denial types are beatable. The key is submitting complete evidence with the initial claim — not waiting for the VA to ask for it. Most denials that come back with a "submit additional evidence" notice are the result of an incomplete initial submission. See: VA Claim Denied Guide → and VA Appeals Guide →

Frequently asked questions

VA Asthma Claims FAQ — 8 questions veterans ask most.

Is asthma a PACT Act presumptive condition?
Yes — asthma diagnosed after service is explicitly listed as a PACT Act §1119 presumptive condition under 38 CFR 3.320 for veterans who served in a covered PACT Act location during the qualifying window. The law was designed with asthma in mind and the eCFR text names asthma alongside chronic rhinosinusitis, chronic bronchitis, COPD, and constrictive bronchiolitis. The strongest respiratory cluster framing for a Gulf War or post-9/11 burn-pit veteran: file chronic rhinosinusitis, chronic bronchitis, and asthma together under PACT Act §1119 presumptive — each as its own diagnostic code with its own rating. Full PACT Act guide: /pact-act · PACT Act denials: /pact-act-denied
How does the VA rate asthma under DC 6602?
Under 38 CFR 4.97 DC 6602, the rating formula is a PFT ladder keyed to FEV1 % predicted and FEV1/FVC ratio. The five levels: 0% — intermittent, no more than two episodes per year with no chronic symptoms (service connected only, $0/mo); 10% — persistent mild, FEV1 ≥80% predicted, FEV1/FVC >0.71, daily symptoms, more than two episodes per year (~$175/mo 2026); 30% — persistent moderate, FEV1 50–79% predicted, FEV1/FVC 0.61–0.70, daily symptoms, nighttime awakenings 1–2×/month (~$524/mo 2026); 60% — persistent severe, FEV1 40–49% predicted, FEV1/FVC ≤0.60 (~$1,361/mo 2026); 100% — persistent very severe, FEV1 <40% predicted, FEV1/FVC <0.40, frequent hospitalizations (~$4,233/mo 2026, the DC 6602 max). The diagnostic standard requires reversible airflow obstruction: ≥12% and ≥200 mL FEV1 improvement after bronchodilator administration. Service connection at 0% is valuable because asthma is a gateway to many secondary claims (the shared-airway-inflammation cluster, GERD-asthma pathway) and preserves future rating increases.
What is the shared-airway-inflammation pathway linking rhinitis, sinusitis, and asthma?
The shared-airway-inflammation pathway is the clinical concept that the upper airway (nose and sinuses) and lower airway (bronchi and lungs) function as a single integrated respiratory epithelium. Chronic rhinitis and chronic sinusitis produce persistent mucosal inflammation that propagates downstream into the bronchial mucosa via the same inflammatory mediators (eosinophils, mast cells, T-helper-2 cytokines), driving airway hyperresponsiveness and asthma. The pathway is the basis for the diagnostic and treatment umbrella term "united airway disease." For VA claims, the pathway establishes a clear secondary service-connection argument under 38 CFR 3.310: a service-connected rhinitis (DC 6522) or chronic sinusitis (DC 6510–6514) can cause or aggravate asthma (DC 6602). The strongest framing: a single ENT + pulmonology co-signed nexus letter addressing the airway-disease module. See /rhinitis-va-claim and /sinusitis-va-claim for the upper-airway pair.
What evidence do I need for an asthma VA claim?
Seven pieces: (1) spirometry / PFT report with FEV1 % predicted, FEV1/FVC ratio, and a documented bronchodilator response ≥12% and ≥200 mL FEV1 improvement (the reversible-airflow-obstruction diagnostic standard for asthma); (2) pulmonology or primary care diagnosis note specifying ICD-10 J45.x with the severity subcode (J45.20 mild intermittent, J45.30 mild persistent, J45.40 moderate persistent, J45.50 severe persistent); (3) 5-field peak-flow log (date, AM peak flow, PM peak flow, rescue inhaler puffs, triggers / symptoms / activity limitation) tracked prospectively for 6 to 12 weeks — this is the strongest defense against the single-snapshot C&P exam problem; (4) ER / urgent care visit records for acute exacerbations; (5) medication reconciliation pharmacy records — albuterol rescue + ICS (fluticasone, budesonide) + LABA (salmeterol, formoterol) + LAMA (tiotropium) + leukotriene modifier (montelukast) + biologics (omalizumab/Xolair, mepolizumab/Nucala, dupilumab/Dupixent) — documentation of escalation to triple therapy and biologics is gold-standard severity evidence; (6) PACT Act deployment and exposure documentation if filing under §1119 presumptive (DD-214, deployment orders, burn-pit proximity buddy statements); (7) asthma-as-secondary-to-GERD nexus letter (pulmonary + GI co-signed) OR shared-airway-inflammation nexus letter (ENT + pulmonary) addressing the rhinitis-sinusitis-asthma cluster.
What is the C&P exam obstacle for asthma — and how do I win the 100% rating?
The obstacle is the single-snapshot FEV1 measurement gap. The Respiratory Conditions DBQ records the FEV1 and FEV1/FVC at the C&P exam visit. Three failure modes: (1) the exam catches a high-flow day — controlled setting suppresses typical trigger exposure; (2) timing of rescue inhaler — pre-exam albuterol artificially opens the airways; (3) rest effect — examiner's rest instructions produce a higher-than-typical FEV1. The defense to win 100%: (1) submit serial PFTs from your pulmonologist showing FEV1 variability and the bronchodilator response explicitly documented; (2) submit the 5-field peak-flow log tracked over 6 to 12 weeks with AM/PM differential and rescue-inhaler puffs; (3) submit pharmacy fill records showing escalation to triple therapy (ICS + LABA + LAMA) or biologics (Xolair / Nucala / Dupixent); (4) submit ER visit records and hospitalization history for acute exacerbations; (5) have your pulmonologist write a letter describing your typical baseline outside the exam room. Full C&P prep: /c-p-exam
How does asthma combine with rhinitis and sinusitis to push combined ratings higher?
The respiratory cluster has three legs — rhinitis (DC 6522), sinusitis (DC 6510–6514), and asthma (DC 6602) — and the shared-airway-inflammation pathway is the clinical anchor that ties them together. The highest-leverage combined-rating stack: 60% asthma + 30% rhinitis + 50% sinusitis = 90%+ combined rating. Even the moderate tier — 30% asthma + 30% rhinitis + 50% sinusitis = 75% combined — crosses the major 70% combined-rating benefits gate (housing allowance, dependents' educational assistance, CHAMPVA eligibility once permanent total disability is also established). The strategy: file all three together under PACT Act §1119 presumptive (38 CFR 3.320) if eligible, OR under 38 CFR 3.310 shared-airway-inflammation secondary nexus if not, with a single ENT + pulmonology co-signed nexus letter addressing the airway-disease module. Combined Ratings Calculator: /calculator · Secondary Conditions map: /secondary-conditions
How do I file asthma as secondary to GERD?
The GERD-as-secondary-to-asthma pathway runs through two parallel mechanisms: (1) microaspiration — chronic reflux of gastric contents into the airways produces direct bronchial irritation, mucosal inflammation, and airway hyperresponsiveness; (2) vagal-mediated bronchospasm — acid in the distal esophagus triggers vagal afferent fibers that produce reflex bronchospasm in the lower airway. Both are documented causes of "GERD-associated asthma" that worsens when reflux is uncontrolled and improves when reflux is treated. For VA claims, the pathway establishes a clear secondary service-connection argument under 38 CFR 3.310: a service-connected GERD (DC 7346) can cause or aggravate asthma (DC 6602). The strongest filing: a single pulmonology + GI co-signed nexus letter addressing both mechanisms, with citation to peer-reviewed GERD-asthma literature, paired with documentation of GERD diagnosis and GERD medication ladder (omeprazole, pantoprazole, esomeprazole, famotidine).
What should I do if my asthma VA claim was denied?
Three denial types and how to fight each: (1) "Single FEV1 reading ≥80%, denied at 0%" — submit serial PFTs from your pulmonologist showing FEV1 variability; submit the 5-field peak-flow log tracked prospectively showing AM/PM differential; submit bronchodilator-response documentation; submit ER records for acute exacerbations with FEV1 below 80%. (2) "No in-service asthma documentation" — file under PACT Act §1119 presumptive (38 CFR 3.320) for covered PACT Act service, OR file asthma as secondary to rhinitis / sinusitis (shared-airway-inflammation) or to GERD (microaspiration / vagal-bronchospasm) under 38 CFR 3.310 with a single co-signed nexus letter naming the mechanism. (3) "Pre-existing asthma, denied as not aggravated" — file under 38 CFR 3.310(b) aggravation pathway with a clear pre-service vs. in-service vs. post-service FEV1 / peak-flow trajectory and a pulmonology nexus letter explicitly invoking the aggravator standard. Most denials are beatable on Supplemental Claim with new evidence within one year. See: /denied-claim and /appeals · For PACT Act denials: /pact-act-denied
Where to go from here

Continue your claim research — all free, all veteran-to-veteran.

The upper-airway pair Rhinitis VA Claims Guide The paired upper-airway condition to asthma under the shared-airway-inflammation pathway. 30% rhinitis (DC 6522) + 50% sinusitis (DC 6510) + 60% asthma (DC 6602) = 90%+ combined rating. The chronic-sinus companion Sinusitis VA Claims Guide Chronic rhinosinusitis DC 6510–6514 — also presumptive under PACT Act §1119. The airway-disease module pairs rhinitis + sinusitis + asthma under a single ENT + pulmonology nexus co-signed letter. Calculate VA Combined Ratings Calculator See how 60% asthma (DC 6602) + 50% sinusitis (DC 6510) + 30% rhinitis (DC 6522) = 90%+ combined — and what you'll earn. Run the actual VA combined-rating math. Stack your rating Secondary Conditions Guide Asthma-as-secondary to rhinitis, sinusitis, GERD, or service-connected respiratory conditions is one of the highest-leverage filings in the respiratory cluster. PACT Act presumptives PACT Act Presumptives Guide Asthma diagnosed after service IS a PACT Act §1119 presumptive condition under 38 CFR 3.320 for veterans who served in a covered PACT Act location during the qualifying window. Every §1119 condition PACT Act §1119 Presumptive Conditions Hub The hub page — asthma and the other §1119 presumptive conditions (chronic rhinosinusitis, rhinitis aggravator, hypertension aggravator) bundled in one place with the effective-date timeline and the reduced evidentiary burden. If the VA said no PACT Act Denied Guide Specific appeal paths for PACT Act denials — including asthma presumptive denials and respiratory-cluster denials. Don't go in blind C&P Exam Prep Guide What the Respiratory Conditions DBQ asks, how to bring your 5-field peak-flow log and serial PFTs, and how to read the exam report afterward. After a denial VA Claim Denied Guide What the denial letter means, what options you have, and the exact one-year clock you have to act. Appeal options HLR, Supplemental & Board Appeals The three AMA appeal lanes explained for asthma denials — Supplemental Claim with new evidence (serial PFTs + peak-flow log) is often the fastest path to a higher rating. Stay informed Free Claims Newsletter PACT Act updates, rating-table changes, and new C&P patterns delivered to veterans monthly. No spam.
Ask on the HadIt Forum — 26,000 veterans who've fought the same fight →

29 years. Veteran-run. No lawyers, no paywalls, no ads.

HadIt.com has operated since 1997 — built by veterans, for veterans, with no financial stake in your claim outcome. Asthma is the third leg of the chronic respiratory cluster — paired with rhinitis and sinusitis through the shared-airway-inflammation pathway — and one of the highest-leverage combined-rating stackers when all three are filed together under PACT Act §1119 presumptive. And most veterans don't know that 60% asthma + 50% sinusitis + 30% rhinitis pushes combined ratings across the 90% bracket. This guide exists to change that.

If it helped you, consider supporting the site so it's here for the next veteran whose asthma claim was just denied at 0% because a single C&P exam FEV1 reading missed the chronic variability.

Support HadIt.com
29 Years running
26k Forum members
$0 Cost to veterans
0 Lawyers involved